Omnicef 500mg Injection

Description

Omnicef 500mg Injection is a third-generation cephalosporin antibiotic containing Cefotaxime. It is used to treat a broad range of moderate to severe bacterial infections. Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injection is NPPA regulated and should be administered under medical supervision.

The 500mg dose is commonly prescribed for adults and older children with moderate infections.

Uses

• Lower and upper respiratory tract infections – pneumonia, bronchitis, sinusitis, tonsillitis

• Urinary tract infections (UTIs)

• Skin and soft tissue infections

• Bone and joint infections

• Intra-abdominal infections (peritonitis, post-surgical infections)

• Septicemia (bloodstream infections)

• Meningitis (bacterial infection of the CNS)

• Gynecological infections

How It Works

Cefotaxime binds to penicillin-binding proteins (PBPs) in bacterial cell walls, inhibiting cell wall synthesis. This weakens the bacterial cell wall and leads to bacterial death, effectively treating the infection.

Side Effects

Common:

• Pain, redness, or swelling at injection site

• Nausea, vomiting, diarrhea

• Mild rash, headache, or fever

Serious (rare):

• Severe allergic reactions (anaphylaxis, swelling, difficulty breathing)

• Blood disorders (low platelets, anemia, leukopenia)

• Liver enzyme elevation or jaundice

• Clostridium difficile-associated diarrhea

Precautions

• Avoid in patients allergic to cephalosporins or penicillins

• Use with caution in renal or hepatic impairment (dose adjustment may be needed)

• Not recommended for neonates with hyperbilirubinemia

• Use in pregnancy and breastfeeding only if prescribed by a doctor

Administration

• Administered via intravenous (IV) or intramuscular (IM) injection by a healthcare professional

• Dosage depends on age, weight, infection type, and severity

• The 500mg dose is typically used for adults and older children with moderate infections